Lipella Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LIPO and buy or sell other stocks, ETFs, and their options commission-free!About LIPO
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent.
CEOJonathan Kaufman
CEOJonathan Kaufman
Employees7
Employees7
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2005
Founded2005
Employees7
Employees7
LIPO Key Statistics
Market cap3.83K
Market cap3.83K
Price-Earnings ratio-3.97
Price-Earnings ratio-3.97
Dividend yield—
Dividend yield—
Average volume434.56K
Average volume434.56K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.50
52 Week high$1.50
52 Week low$0.2804
52 Week low$0.2804
Stock Snapshot
The current Lipella Pharmaceuticals(LIPO) stock price is $0.00, with a market capitalization of 3.83K. The stock trades at a price-to-earnings (P/E) ratio of -3.97.
On 2026-11-22, Lipella Pharmaceuticals(LIPO) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 434.56K.
The stock's 52-week range extends from a low of $0.28 to a high of $1.50.
The stock's 52-week range extends from a low of $0.28 to a high of $1.50.
People also own
Based on the portfolios of people who own LIPO. This list is generated using Robinhood data, and it’s not a recommendation.